Degradable polymers have been used successfully in a wide variety of peripheral applications from tissue regeneration to drug delivery. These polymers induce little inflammatory response and appear to be well accepted by the host environment. Their use in the brain, for neural tissue reconstruction or drug delivery, also could be advantageous in treating neurodegenerative disorders. Because the brain has a unique immune response, a polymer that is compatible in the body may not be so in the brain. In the present study, polyethylene glycol (PEG)-based hydrogels were implanted into the striatum and cerebral cortex of nonhuman primates. Four months after implantation, brains were processed to evaluate the extent of astrogliosis and scaring, the presence of microglia/macrophages, and the extent of T-cell infiltration. Hydrogels with 20% w/v PEG implanted into the brain stimulated a slight increase in astrocytic and microglial/macrophage presence, as indicated by a small increase in glial fibrillary acidic protein (GFAP) and CD68 staining intensity. This increase was not substantially different from that found in the sham-implanted hemispheres of the brain. Staining for CD3+ T cells indicated no presence of peripheral T-cell infiltration. No gliotic scarring was seen in any implanted hemisphere. The combination of low density of GFAP-positive cells and CD68-positive cells, the absence of T cells, and the lack of gliotic scarring suggest that this level of immune response is not indicative of immunorejection and that the PEG-based hydrogel has potential to be used in the primate brain for local drug delivery or neural tissue regeneration.
INTRODUCTION
include polymers that slowly release drugs, proteins, or viral vectors to provide local treatment with compounds that often do not penetrate the blood-brain barrier, have Artificial polymers have gained interest in medicine as devices that can assist in tissue regeneration and drug debilitating side effects, or poor bioavailability. Carmustine (BCNU), a common brain tumouricidal agent with delivery. Polymeric agents have been developed as templates for regenerating tissue specifically in orthopedics, a short half-life and dose-limiting side effects, was one of the first compounds put into microspheres and discs, vascular stent grafts, and peripheral nerve conduit repair (1, 16, 21, [28] [29] [30] 32, 40, 42, 44, 47, 50, 51) . As drug delivery for implantation into brain tumors (9, 10, 49) . These discs (i.e., the Gliadel system) proved to be successful besystems, they have been used for contraceptives, narcotic antagonists, antitumorgenic agents, and growth faccause BCNU remained stable in the polymer and was released in relevant and sustained concentrations at the tors (7, 15, 17, 22, 23, 26, 28, 29, 37, 49, 53) . Because degradability can be incorporated into the polymer, there is tumor site. Polylactide (PL), polyglycolide (PG), and copolyno need for their removal via a second invasive surgery. In the periphery, most polymeric agents have shown mers of lactide/glycolide (PLGA), are among the most commonly used biomaterials in medicine. These polygood biocompatibility in that there has been little fibrous encapsulation, no polymer-induced necrosis, and they meric agents have been implanted into the brain and have shown good biocompatibility and sustainable drug have facilitated tissue regeneration.
In the central nervous system (CNS), polymers could delivery. In normal untreated animals, polymer microspheres implanted into the brain did not produce gross be helpful in the regeneration of damaged neural tissue resulting from stroke or neurodegenerative disorders.
behavioral or neurological symptoms up to 1 year postimplant (11, 12, 18) . At the cellular level, PLGA-based Currently polymer treatment being tested in the brain 410 BJUGSTAD ET AL.
polymer microspheres did induce a local inflammatory for implantation into the nonhuman primate brain. The rate of hydrogel degradation was controlled by altering response, but it was not any greater than a needle pass into the brain (18, 53) . Minimal fibrosis was seen around the concentration of PEG in the hydrogel solution rather than the number of lactic acid units, which remained the microspheres and an increase in reactive astrocytes, which peaked around 7 days postimplantation into the constant for all hydrogels (ϳ1.7 units per macromer). Hydrogels were formed as either a 13% (faster degradstriatum and diminished as the polymer degraded (18, 22, 37, 53) . Examination of the PLGA implantation ing) or 20% (slower degrading) weight/volume polyethylene glycol macromer concentration. In addition, half site 1 year later showed no signs of edema, lymphocytes, eosinophiles, or foreign giant cell bodies (18) . Tolerable of the 20% hydrogels were incorporated with GDNF (human recombinant GDNF, Chemicon; 2.5 ng per strand) biocompatibility is not always obtained when using other polymeric agents. Poly(methylidene) malonate (PMM)-by adding the GDNF to the prepolymer solution.
Five healthy normal untreated St. Kitts green monbased microspheres implanted into rat striatum induced no more CNS inflammation than sham injections in the keys (Chlorocebus sabaeus) were used in this study in accordance with the National Institutes of Health Guide days following implantation and before the degradation process began. However, once the PMM microspheres for the Care and Use of Laboratory Animals. They were housed at the St. Kitts Biomedical Research Foundation began to degrade, several months later, significant inflammation, necrosis, and even death of some animals (St. Kitts, West Indies). All monkeys were implanted bilaterally through the frontal cortex and striatum using occurred. Interestingly, PMM had a good long-term biocompatibility profile when used outside the CNS (19) .
an oblique penetration (40°from vertical) controlled by a Kopf stereotaxic device. In one hemisphere the needle In the present study, we examined the biocompatibility of polyethylene glycol (PEG)-based hydrogels in the was loaded with a 10-mm-long, 250-µm-diameter, degradable PEG hydrogel strand that was extruded into the nonhuman primate brain. Hydrogels are water-swellable cross-linked polymer networks with a high level of elasstriatum and then frontal cortex during retraction of the needle. The other hemisphere was sham implanted in ticity, making them ideal candidates for tissue engineering (4, 38, 41) . PEG-based hydrogels have attracted the which the transplant needle penetrated the brain but no polymer was extracted. One animal was implanted bilatattention of researchers for a variety of applications in drug delivery and tissue engineering because they are erally with GDNF incorporated into a 20% PEG hydrogel. No immunosuppression was given to any animal. highly hydrated, nonionic, and relatively resistant to protein adsorption (43) . In vitro, they can support the surBrains were collected at 4 months postimplantation for histological analysis. Animals were overdosed with penvival of PC12 cells, fetal ventral mesencephalic neural cells, and human neural progenitor cells (34) (35) (36) 48) . In tobarbital and perfused with ice-cold physiological saline, followed by 4% paraformaldehyde fixation. Once this study, the biocompatibility of the PEG hydrogel in the nonhuman primate brain was determined by implantextracted, brains were fixed for an additional 12 h and then stored in 30% sucrose buffer at 4°C until sectioning strands of polymer that bridged the striatum to the cortex and examining the presence of astrogliotic scaring. Parasagittal brain sections, 50 µm thick, were used for free-floating immunohistochemistry. ing, reactivity of microglia/macrophages, and the infiltration of T cells.
To evaluate the reaction of the primate brain to PEGbased hydrogel implants, we compared the presence of MATERIALS AND METHODS gliotic scarring, microglia activation, and the presence of T cells between hydrogel-implanted and sham-implanted A triblock polymer of PEG, PLA, and methacrylate (MA) end groups was synthesized and purified in accorhemispheres. Immunohistology was done using primary antibodies against glial fibrillary acidic protein for astrodance with the literature (43) . This macromer was dissolved in sterile physiologic saline and the photoinitiagliotic scarring (GFAP; Chemicom MAB3402, 1:500), CD68 for microglial/macrophage activation (Serotec, tor, Irgacure 2959, was added to make a prepolymer solution. When exposed to ultraviolet light the prepoly-MCA1815, 1:150), and CD3 for T-cell infiltration (Serotec, MCA463G, 1:100). Primary antibodies were incumer solution formed a degradable hydrogel strand by radical propagation through the MA end groups. This bated overnight at room temperature. To visualize GFAP immunopresence, 3,3′-diaminobenzidine (DAB) was used created a three-dimensional network of polymethacrylate chains and PLA-PEG-PLA cross-linkers (35) . Apwithout nickel, while nickel enhancement was used for CD68-positive and CD3-positive immunostaining. proximately 2.5-3 µl of the prepolymer solution was inserted into a sterile glass capillary tube and exposed
The intensity of GFAP and CD68 staining was measured in arbitrary optical density units (AOD) using Mito ultraviolet light (365 nm, 4 mW/cm 2 ) for 2 min to polymerize. The polymerized hydrogel was extracted crosuite5/Biologicalsuite (Olympus) software. Digital pictures were taken of each brain section containing the from the glass tube and loaded into an 18-gauge needle implant track. Pixel intensity measures were taken every decreased away from the track (Fig. 2 ). In addition, there was still no dense gliotic border separating the pa-0.8 µm from the border of the implant track to 300 µm away from the track. Every 10 intensity measures were renchyma from the track. Most hemispheres had very few CD68-positive cells in the striatum and the cortex. then averaged to create an 8-µm mean intensity measure. Group mean measures were then graphed for relaPositive cells had a large soma with short processes, suggestive of reactive microglia/macrophages. Unreactive comparisons between groups. The following groups were compared: sham (n = 4 hemispheres), 13% PEG tive microglia/macrophages were observed in areas more than 50 µm from implant track only in sham-implanted (n = 2 hemispheres), 20% PEG (n = 2 hemispheres), and 20% PEG with GDNF (20% GDNF; n = 2 hemispheres).
hemispheres, as indicated by light immunostaining and long processes (Fig. 2A) . The 20% GDNF-implanted RESULTS hemispheres overall had the highest intensity of CD68 immunopresence in the striatum compared to other At the end of 4 months, all animals were healthy with no apparent neurological or behavioral impairments.
groups (Fig. 2B ). Figure 2B also shows the yellow hemosiderin-positive cells within the track, although this Histological analysis revealed that neither the faster degrading hydrogels (13% PEG) nor the slower degrading effect was not exclusive to the 20% GDNF hemispheres or the striatum. In the cortex, one of the two 13% PEGhydrogels (20% PEG) could be located in the brain sections, suggesting a complete degradation of both polyimplanted hemispheres had a large number of CD68-positive cells near the transplant track (Fig. 2E) ; howmers during the posttransplant period. The tracks from the hydrogel-implanted sides had a similar appearance ever, the other 13% hemisphere had very few cells, suggesting that the microglia/macrophage response is as sham tracks. Usually only a thin seam was present in the cortex and striatum, but occasionally the tracks not specific to the hydrogel itself but another aspect of the transplant procedure (i.e., proximity of the transplant contained clusters of yellow hemosiderin-positive cells (Fig. 2B ). These observations were seen in hydrogel penetration to cerebral vasculature) (Fig. 2E ). T-cell infiltration from the periphery was not evident hemispheres and the sham hemispheres.
An increase in the number of astrocytes, as indicated in any hemisphere regardless of sham implant or polymer implantation. by GFAP-positive immunoreactivity, was observed near all implant tracks. No dense GFAP-positive reactive DISCUSSION border separating the surrounding parenchyma of the striatum or the cortex from the implant was observed in Based on our observations of how the nonhuman primate brain responds to PEG-based hydrogels inserted any group. As seen in the line graphs of Figure 1 , there was a small increase in GFAP staining near the track into the striatum and cortex, the astrocytic response and microglial/macrophage response is minimal and does which gradually lessened up to 300 µm away from the track. In the striatum, as compared to the cortex, astronot appear to be destructive. No gliotic scaring, as indicated by a dense GFAP-positive or CD68-positive borcytes tended to have a more reactive appearance in that cells had many long, darkly stained processes (Fig. 1A, der walling the hydrogel track from the brain parenchyma, was observed in any PEG-or sham-implanted B, D, E). Compared to the sham-implanted striatum, the 20% PEG and 20% GDNF sides had a greater intensity hemisphere. The 20% w/v PEG hydrogels had a slight increase in both GFAP and CD68 presence compared to of GFAP staining, whereas the 13% PEG had the lowest levels (Fig. 1C) . Only one sham side and one 20% PEG sham implants. Only one 13% PEG hydrogel-implanted hemisphere had a substantial increase in CD68-positive side was observed to have only small, short processed astrocytes, considered to be unreactive. By comparison, cells at the implant track, which suggests that the location of the implant was most likely the reason for inthe cortex had less GFAP staining with fewer reactive astrocytes. Both 13% PEG-implanted hemispheres had crease in CD68-positive cell infiltration rather than the polymer itself. primarily unreactive astrocytes, along with one shamand one 20% PEG-implanted hemisphere. The 20%
Although the inflammation process in the brain is typically thought of as an undesirable effect, usually GDNF had the greatest intensity of GFAP staining in the cortex compared to the other groups. The photomicausing more damage, it also can be a healing response (2, 3, 24) . Previous studies have shown that microglia/ crographs in Figure 1 were taken from sections that had the highest levels of GFAP intensity staining found in macrophages are the first responders in a damaged brain environment (6, 20) . Within 24 h, microglia/macroboth sham-implanted and hydrogel-implanted hemispheres. Figure 1B and 1E micrographs were taken from phages migrate into the damaged area to phagocytize dead cells, but they are also found to release the growth hemispheres implanted with a 20% PEG hydrogel.
Like staining for GFAP, there was an increase in factors GDNF and brain-derived neurotrophic factor (BDNF) during times of neural inflammation (6,27,33, CD68 staining near the transplant track that gradually Hemispheres that had the darkest and most dense GFAP staining are presented in the photomicrographs (A, B, D, E) to show the greatest astrocytic response at the transplant track (arrows) obtained in our studies. Immunostaining in the striatum of shamimplanted (A) and 20% PEG hydrogel-implanted (B) hemispheres display reactive astrocytes near the implant track, with dense somas and long processes. Intensity profile measures of GFAP staining were measured in pixel intensity with high numbers representing high intensity (high white content) and low numbers representing low intensity (high dark content). In the striatum, GFAP intensity profiles suggest that the two hemispheres implanted with the 20% w/v PEG strands had more GFAP presence than sham or 13% w/v PEG strands. In the cortex, (D, E) the astrocytes appear less reactive with lighter staining and fewer processes compared to the striatum. Again, the 20% PEG-implanted hemispheres had a greater GFAP presence, compared to the GDNF 20%, the sham, and the 13% PEG (F). Scale bar: 200 µm for all photomicrographs. 46 ). Over the course of several weeks to months, the cess, this concentration of PEG in the hydrogel may stimulate the glial response longer. The addition of microglial/macrophage presence diminishes, although Batchelor et al. (6) found that some microglia remain at GDNF into the 20% PEG hydrogels produced a slight increase in CD68-positive cell presence. Honda et al. the wound site long term and may even assist in new neuronal sprouting. Astrocytes respond several days (25) found that microglia express GDNF receptors, which, when stimulated, regulate some of the microglial after the microglial/macrophage response (6, 20) . Like microglia, astrocytes can also release healing growth functions. The moderate decrease in GFAP presence as a result of GDNF incorporated into the 20% PEG hydrofactors (5, 13) . Previous studies have found that microglia and astrocytes play an important role in rescuing strigel is also consistent with other findings. Wood et al. (52) found that GDNF does not increase the number of atal and cortical neurons from ischemic or quinolinic damage, stimulating oligodendrogenesis and neurogen-GFAP cells in culture but stimulates additional growth factor release from the astrocytes already present. esis from neural progenitor cells, and promoting neurogenesis in the olfactory bulb and hippocampus (6,8,13, We also found no evidence of CD3-positive T cells in any hydrogel-or sham-implanted hemisphere. Some 27,31, 46, 54) .
Our results demonstrate that microglia and astrocytes studies have suggested that T-helper cells determine the type of glial-initiated inflammatory response through remained for at least 4 months in and around the implantation site. The 20% w/v PEG hydrogel strands tended their release of either cytokines, like interleukin-4 or interferon-γ, which induce a healing inflammatory reto have a greater effect on microglia and astrocytes than the 13% or sham. Because of the slower degrading prosponse, or tumor necrosis factor-α and nitric oxide, Figure 1 , hemispheres with the darkest CD68 staining are presented in the photomicrographs (A, B, D, E) to demonstrate the greatest microglial/macrophage response observed in this study. Cells with dark short processes (i.e., CD68 positive) were observed at the transplant track (arrow) of all implanted groups; however, unreactive microglia also were seen in the striatum of sham-implanted hemispheres removed from the track as indicated by light staining and longer processes (A). Yellow, hemosiderin-positive cells are shown in the striatum of a 20% GDNF-implanted hemisphere (B); however, these cells were not exclusive to this implant group or to this study. All transplant tracks were found to have hemosiderin-positive cells, a common feature in many transplanted brains. Again, intensity profile measures were quantified in pixel intensity with high numbers representing high intensity (high white content) and low numbers representing low intensity (high dark content). The line graph in (C) shows comparative levels of CD68 presence between the groups, with the 13% PEG-implanted hemispheres showing the least CD68 presence. Unlike the striatum, one 13% PEG-implanted hemisphere appeared to have a dense population of CD68-positive cells (E). The relative intensities between the groups in the cortex can be seen in (F). Notice the 13% PEG line in comparison to the other groups and the graphed data in (C). Despite this substantial increase, it still does not appear as a gliotic wall separating the track from the parenchyma.
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which lead to neurotoxicity (2, 3, 14, 24, 39, 45 Because of the lack of gliotic scaring at the transplant site, and the sparse gliotic presence in hydrogel-implanted REFERENCES hemispheres, we conclude that both the 13% w/v and protective rather than destructive.
